Prevention of acute and delayed chemotherapy-induced nausea and vomiting in pediatric cancer patients: A clinical practice guideline

Priya Patel, Paula D. Robinson, Marie Cohen, Katie Devine, Paul Gibson, Mark T. Holdsworth, Eloise Neumann, Andrea Orsey, Robert Phillips, Daniela Spinelli, Jennifer Thackray, Marianne van de Wetering, Deborah Woods, Sandra Cabral, Lillian Sung, L. Lee Dupuis

Onderzoeksoutput: Bijdrage aan tijdschriftArtikelpeer review

Samenvatting

This clinical practice guideline provides recommendations for preventing acute and delayed phase chemotherapy-induced nausea and vomiting (CINV) in pediatric patients. The recommendations are based on two systematic reviews of randomized controlled trials evaluating interventions to prevent (1) acute phase CINV and (2) delayed phase CINV. Recommendations for acute phase and delayed phase CINV prophylaxis are made for patients receiving chemotherapy of varying emetogenicity, as well as for patients not able to receive dexamethasone or a neurokinin-1 receptor antagonist. Evidence gaps, including antiemetic safety and optimal dosing, were identified.

Originele taal-2Engels
Artikelnummere30001
Pagina's (van-tot)e30001
TijdschriftPediatric Blood and Cancer
Volume69
Nummer van het tijdschrift12
DOI's
StatusGepubliceerd - dec. 2022

Vingerafdruk

Duik in de onderzoeksthema's van 'Prevention of acute and delayed chemotherapy-induced nausea and vomiting in pediatric cancer patients: A clinical practice guideline'. Samen vormen ze een unieke vingerafdruk.

Citeer dit